Growth Factor Regulation of Fetal Growth

Fetal and Neonatal Physiology: Third Edition

Volumn 2-2, Issue , 2003, Pages 1880-1890

  De León, Diva D ^a,b   Cohen, Pinchas ^c   Levitt Katz, Lorraine E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890294145     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50186-7     Document Type: Chapter

References (146)

1. Rotwein P Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Fact 1991, 5:3.
2. LeRoith D, et al. Insulin-like growth factors. Biol Signals 1992, 1:173.
3. Nielsen FC The molecular and cellular biology of insulin-like growth factor II. Prog Growth Fact Res 1992, 4:257.
4. Oh Y, et al. New concepts in insulin-like growth factor receptor physiology. Growth Regul 1993, 3:113.
5. Nissley P, Lopaczynski W Insulin-like growth factor receptors. Growth Fact 1991, 5:29.
6. White MF IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002, 283:E413.
7. Nakae J, et al. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 2001, 22:818.
8. Kalscheuer VM, et al. The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat Genet 1993, 5:74.
9. Moxham CP, et al. Insulin-like growth factor-I receptor β-subunit heterogeneity: evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem 1989, 264:13238.
10. Zhang B, Roth RA The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities. J Biol Chem 1992, 267:18320.
11. Kitamura T, et al. Preserved pancreatic β-cell development and function in mice lacking the insulin receptor-related receptor. Mol Cell Biol 2001, 21:5624.
12. Lamson G, et al. Insulin-like growth factor binding proteins: structural and molecular relationships. Growth Fact 1991, 5:19.
13. Baxter RC, et al. Recommendations for nomenclature of the insulin-like growth factor binding proteins superfamily. Endocrinology 1998, 139:4036.
14. Pilia G, et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 1996, 12:241.
15. Donovan SM, et al. Ontogeny of serum insulin-like growth factor binding proteins in the rat. Endocrinology 1989, 125:2621.
16. Cohen P, et al. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 1993, 7:380.
17. Valentinis B, et al. The human insulin-like growth factor binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 1995, 9:361.
18. Clemmons DR Insulin-like growth factor binding proteins: roles in regulating IGF physiology. J Dev Physiol 1991, 15:105.
19. Grimberg A, Cohen P Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000, 183:1.
20. Erondu NE, et al. Regulation of endothelial IGFBP-3 synthesis and secretion by IGF-I and TGF-beta. Growth Regul 1996, 6:1.
21. Gucev ZS, et al. Insulin-like growth factor binding protein 3 mediates retinoic acid and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res 1996, 56:1545.
22. Han GR, et al. All-trans-retinoic acid increases transforming growth factor2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway. J Biol Chem 1997, 272:13711.
23. Rajah R, et al. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor1 on programmed cell death via a p53- and IGF-independent mechanism. J Biol Chem 1997, 272:12181.
24. Lamson G, et al. Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Reg 1993, 3:91.
25. Davenport ML, et al. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 1990, 127:1278.
26. Giudice LC, et al. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 1990, 71:806.
27. Cotterill AM, et al. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism. J Clin Endocrinol Metab 1992, 74:56.
28. Cohen P, et al. Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol [Copenh] 1991, 124:74.
29. Bhala A, et al. Insulin-like growth factor axis parameters in sick hospitalized neonates. J Pediatr Endocrinol Metab 1998, 11:451.
30. Cohen P, et al. Prostate-specific antigen (PSA) is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma. J Clin Endocrinol Metab 1992, 75:1046.
31. Rajah R, et al. 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 1996, 137:2676.
32. Conover CA, De Leon DD Acid-activated insulin-like growth factor-b. J Biol Chem 1994, 269:7076.
33. Fowlkes JL, et al. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 1994, 269:25742.
34. Cohen P, et al. Biological effects of prostate-specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 1994, 142:407.
35. Velinov M, et al. The gene for achondroplasia maps to the telomeric region of chromosome 4p. Nature Genet 1994, 6:314.
36. D'Ercole AJ Growth factors and development. Fetal and Neonatal Physiology 1991, 1820-1828. WB Saunders, Philadelphia. R. Polin, W. Fox (Eds.).
37. Adamson ED, Meek J The ontogeny of epidermal growth factor receptors during mouse development. Dev Biol 1984, 103:62.
38. Goldin GV, Opperman LA Induction of supernumerary tracheal buds and the stimulation of DNA synthesis in the embryonic chick lung and trachea by epidermal growth factor. J Embryol Exp Morphol 1980, 60:235.
39. Miettinen PJ, et al. Epithelial immaturity and multi-organ failure in mice lacking EGF receptor. Nature 1985, 376:337.
40. Lee DC, et al. Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha. Nature 1985, 313:489.
41. Rappolee DA, et al. Developmental expression of PDGF, TGF-alpha, and TGF-beta genes in preimplantation mouse embryos. Science 1988, 241:1823.
42. Han VK, et al. Expression of rat transforming growth factor alpha mRNA during development occurs predominantly in the maternal decidua. Mol Cell Biol 1987, 7:2335.
43. Ross R, et al. The biology of platelet-derived growth factor. Cell 1986, 46:155.
44. Östlund E, et al. Transforming growth factor1 in fetal serum correlates with insulin-like growth factor-I and fetal growth. Obstet Gynecol 2002, 100:567.
45. Attisano L, Wrana JL Signal transduction by TGF superfamily. Science 2002, 296:1646.
46. Hahnel A, Schultz GA Insulin-like growth factor binding proteins are transcribed by preimplantation mouse embryos. Endocrinology 1994, 134:1956.
47. Adamson ED Activities of growth factors in preimplantation embryos. J Cell Biochem 1993, 53:280.
48. Kaye PI, et al. Insulin and the insulin-like growth factors in preimplantation development. Reprod Fertil Dev 1992, 4:373.
49. D'Ercole AJ The insulin-like growth factors and in utero growth. Growth Genet Horm 1992, 8:1.
50. Rappolee DA, et al. IGF-II acts through an endogenous pathway regulated by imprinting in early mouse embryos. Genes Dev 1992, 6:939.
51. Smith RM, et al. Mouse preimplantation embryos exhibit receptor-mediated binding and transcytosis of maternal IGF-I. Biol Reprod 1993, 49:1.
52. Palmiter RD, et al. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 1982, 300:611.
53. Palmiter RD, et al. Metallothionein-human GH fusion genes stimulate growth of mice. Science 1983, 222:809.
54. Matthews LS, et al. Expression of IGF-I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 1988, 123:433.
55. Camacho-Hubner C, et al. Regulation of insulin-like growth factor binding proteins in transgenic mice with altered expression of growth hormone and IGF-I. Endocrinology 1991, 129:1201.
56. Wolf E, et al. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. Endocrinology 1994, 135:1877.
57. Behringer RR, et al. Dwarf mice produced by genetic ablation of growth hormone expressing cells. Genes Dev 1988, 2:453.
58. Behringer R, et al. Expression of IGF-I stimulates normal somatic growth in growth hormone transgenic mice. Endocrinology 1990, 127:1033.
59. Murphy LJ, et al. Hormonal regulation of insulin-like growth factor binding protein-1 expression and the development of transgenic mouse models to study IGFBP-1 function. Adv Exp Med Biol 1993, 343:279.
60. Dai Z, et al. Human insulin-like growth factor-binding protein-1 (hIGFBP-1) in transgenic mice: characterization and insights into the regulation of IGFBP-1 expression. Endocrinology 1994, 135:1316.
61. D'Ercole AJ, et al. Brain growth retardation due to expression of human insulin-like growth factor binding protein-1 in transgenic mice: an in vivo model for the analysis of IGF function in the brain. Brain Res Dev Brain Res 1994, 82:213.
62. Hoeflich A, et al. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 1999, 140:5488.
63. Murphy LJ, et al. Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. J Mol Endocrinol 1995, 15:293.
64. Neuenschwander S, et al. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest 1996, 97:2225.
65. Wang J, et al. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 1998, 139:2605.
66. Baker J, et al. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75:73.
67. DiChiara T, et al. A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990, 345:78.
68. DiChiara T, et al. Parental imprinting of the mouse insulin-like growth factor-II gene. Cell 1991, 64:849.
69. Powell-Braxton L, et al. IGF-I is required for normal embryonic development in mice. Genes Dev 1993, 7:2609.
70. Liu JP, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type I IGF receptor. Cell 1993, 75:59.
71. Beck KD, et al. IGF-I gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995, 14:717.
72. Lupu F, et al. Roles of growth hormone and insulin-like growth factor I in mouse postnatal growth. Dev Biol 2001, 229:141.
73. Woods KA, et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996, 335:1363.
74. Yakar S, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 1999, 96:7324.
75. Ueki I, et al. Inactivation of the acid-labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Natl Acad Sci U S A 2000, 97:6868.
76. Yakar S, et al. Circulating levels of IGF-I directly regulate bone growth and density. J Clin Invest 2002, 110:771.
77. Wang ZQ, et al. Regulation of embyonic growth and lysosomal targeting by the imprinted IGF-2/MPR gene. Nature 1994, 372:464.
78. Haig D, Graham C Genomic imprinting and the strange case of the insulin-like growth factor-II receptor. Cell 1991, 64:1045.
79. Ludwig T, et al. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in IGF2 and IGF1r null backgrounds. Dev Biol 1996, 177:517.
80. Louvi A, et al. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 1997, 189:33.
81. Duvillie B, et al. Phenotype alterations in insulin-deficient mutant mice. Proc Natl Acad Sci U S A 1997, 94:5137.
82. Hone J, et al. Homozygosity for a null allele of the insulin receptor gene in a patient with lepreuchaunism. Hum Mutat 1995, 6:17.
83. Tyrala EE The infant of the diabetic mother. Obstet Gynecol Clin North Am 1996, 23:221.
84. DeBaun MR, et al. Hypoglycemia in Beckwith-Wiedemann syndrome. Semin Perinatol 2000, 24:164.
85. Reinecke-Luthge A, et al. The molecular basis of persistent hyperinsulinemic hypoglycemia of infancy and its pathologic substrates. Virchows Arch 2000, 436:1.
86. Pintar JE, et al. Genetic approaches to the function of insulin-like growth factor-binding proteins during rodent development. Horm Res 1996, 45:172.
87. Pintar J, et al. Genetic disruption of IGF binding proteins. Molecular Mechanism to Regulate the Activities of Insulin-like Growth Factors 1998, 65-70. Elsevier Science, Amsterdam. K. Takano (Ed.).
88. Schneider MR, et al. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins. FASEB J 2000, 14:629.
89. Tamemoto H, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994, 372:182.
90. Araki E, et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994, 372:186.
91. Cho H, et al. AKT1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001, 276:38349.
92. Cho H, et al. Insulin resistance and diabetes mellitus-like syndrome in mice lacking the protein kinase AKT2 (PKB beta). Science 2001, 292:1728.
93. Gargosky S, et al. Circulating levels of IGFs increase and molecular forms of their serum binding protein change with human pregnancy. Biochem Biophys Res Commun 1990, 170:1157.
94. Hall K, et al. Serum levels of somatomedins and somatomedin-binding proteins in pregnant women with type I or gestational diabetes and their infants. J Clin Endocrinol Metab 1986, 63:1300.
95. Scippo ML, et al. Syncytiotrophoblast localization of the human growth hormone variant mRNA in the placenta. Mol Cell Endocrinol 1993, 92:R7.
96. Caufriez A, et al. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 1993, 265:E572.
97. Handwerger S The physiology of placental lactogen in human pregnancy. Endocrinol Rev 1991, 12:329.
98. Drop SLS Correlation between fetal IGFBP-1 levels and birthweight. Int Growth Monitor 1994, 4:26.
99. Holly J, et al. Proteases acting on IGFBPs; their occurrence and physiologic significance. Growth Regul 1993, 3:88.
100. Hossenlopp P, et al. Evidence of enzymatic degradation of IGFBPs in the 150 kD complex during pregnancy. J Clin Endocrinol Metab 1990, 71:797.
101. Claussen M, et al. Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid. Endocrinology 1994, 4:1964.
102. Deal C, Guyda HJ Regulation of fetal growth and the GH-IGF axis: lessons from mouse to man. Int Growth Monitor 1995, 4:1.
103. Blat C, et al. In vivo proteolysis of serum IGFBP-3 results in increased availability of IGF to target cells. J Clin Invest 1994, 93:2286.
104. Brice AL, et al. Temporal changes in the expression of the insulin-like growth factor II gene associated with tissue maturation in the human fetus. Development 1989, 106:532.
105. Ohlsson R, et al. IGF-II and short range stimulatory loops in control of human placental growth. EMBO J 1989, 9:1993.
106. Ohlsson R, et al. Blastocyst implantation precedes induction of insulin-like growth factor-II gene expression in human trophoblasts. Development 1989, 106:555.
107. Han VKM, et al. Cellular localization of IGF messenger RNA in the human fetus. Science 1987, 236:193.
108. Funk B, et al. Expression of the IGF-II, M6P receptor in multiple human tissues during fetal life and early infancy. J Clin Endocrinol Metab 1992, 75:424.
109. Hill DH, Clemmons J Similar distribution of IGFBPs 1,2,3 in human fetal tissues. Growth Factors 1992, 6:315.
110. Delhanty PJD, et al. IGFBP 4,5,6 mRNA in the human fetus; localization to sites of growth and differentiation. Growth Regul 1993, 3:8.
111. Lassarre C, et al. IGFs and their binding proteins in human fetal serum; relationships with growth in normal subjects and in subjects with IUGR. Pediatr Res 1991, 29:219.
112. Gluckman PD, et al. Studies of insulin-like growth factor I and II by specific radio ligand assays in umbilical cord blood. Clin Endocrinol (Oxf) 1983, 19:405.
113. Bennett A, et al. Levels of insulin-like growth factors I and II in human cord blood. J Clin Endocrinol Metab 1983, 57:609.
114. Verhaege J, et al. C-peptide, the insulin-like growth factors I and II and IGF binding protein 1 in umbilical cord serum: correlations with birthweight. Am J Obstet Gynecol 1993, 169:89.
115. Wit JM, van Unen H Growth of infants with neonatal growth hormone deficiency. Arch Dis Child 1992, 67:920.
116. Gluckman PD, et al. Congenital idiopathic GH deficiency associated with prenatal and postnatal growth failure. J Pediatr 1992, 121:920.
117. Savage MO, et al. Clinical features and endocrine status in patients with GH insensitivity (Laron syndrome). J Clin Endocrinol Metab 1993, 77:1465.
118. Guidice LC, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995, 80:1548.
119. Martin JA, et al. Births: final data for 2000. Natl Vital Stat Rep 2002, 50:1.
120. Mirlesse V, et al. Placental GH levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res 1993, 34:439.
121. Kajantie E, et al. Markers of type I and type III collagen turnover, insulin-like growth factors and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment. Pediatr Res 2001, 49:481.
122. Verhaeghe J, et al. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol 1993, 169:89.
123. Wang HS, et al. The concentration of insulin-like growth factor I in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol 1991, 129:459.
124. Ducos B, et al. IGF type I receptor ligand binding characteristics are altered in a subgroup of children with intrauterine growth retardation. J Clin Endocrinol Metab 2001, 86:5516.
125. Lajara R, et al. Low prevalence of insulin-like growth factor-I gene mutations in human growth disorders. J Clin Endocrinol Metab 1990, 70:687.
126. Mullis PE, et al. Constitutionally short stature: analysis of the insulin-like growth factor-I gene and the human growth hormone gene cluster. Pediatr Res 1991, 29:412.
127. Arends N, et al. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). J Clin Endocrinol Metab 2002, 87:2720.
128. Ong KL, et al. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 2000, 320:967.
129. Albertsson-Wikland K, Karlberg J Postnatal growth of children born small for gestational age. Acta Paediatr (Suppl) 1997, 423:193.
130. McCowan L, et al. Perinatal predictors of growth at six months in small for gestational age babies. Early Hum Dev 1999, 56:205.
131. Leger J, et al. Prediction factors in the determination of final height in subjects born small for gestational age. Pediatr Res 1998, 43:808.
132. Barker DJ Fetal origins of cardiovascular disease. Ann Med 1999, 31(Suppl 1):3.
133. Kajantie E, et al. IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants. J Clin Endocrinol Metab 2002, 87:2171.
134. Lithell HO, et al. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 1996, 312:406.
135. Hattersley AT, Tooke JE The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999, 353:1789.
136. Barker DJP, et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension, and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetology 1993, 36:62.
137. de Zegher F, et al. High-dose growth hormone treatment of short children born small for gestational age. J Clin Endocrinol Metab 1996, 81:1887.
138. Sas T, et al. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J Clin Endocrinol Metab 2000, 85:3786.
139. Leger J, et al. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal. J Clin Endocrinol Metab 1998, 83:3512.
140. Coutant R, et al. Short stature associated with intrauterine growth retardation: final height of untreated and growth-hormone treated children. J Clin Endocrinol Metab 1998, 83:1070.
141. Zucchini S, et al. Final height of short subjects of low birth weight with and without growth hormone treatment. Arch Dis Child 2001, 84:340.
142. Ranke MB, Lindberg A Growth hormone treatment of short children born small for gestational age or with Silver-Russell syndrome: results from KIGS (Kabi International Growth Study), including the first report on final height. Acta Paediatr (Suppl) 1996, 417:18.
143. Gluckman PD The endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factors. J Clin Endocrinol Metab 1995, 80:1047.
144. Takayama M, et al. Abnormally large placenta associated with Beckwith-Wiedemann syndrome. Gynecol Obstet Invest 1986, 22:165.
145. Weksberg R, et al. IGF-II serum levels are normal in patients with Beckwith-Wiedemann syndrome. Am J Hum Genet 1990, (Suppl). Abstract 323.
146. Leisenring WM, et al. Increased birthweight of national Wilms' tumor study patients suggests growth factor excess. Cancer Res 1994, 5423:4680.